(Q43256269)

17 November 2017

Identifying metabolically healthy but obese individuals in sedentary postmenopausal women (English)

1 reference

17 November 2017

0 references

6

Rémi Rabasa-Lhoret

1 reference

17 November 2017

Virginie Messier

1

1 reference

17 November 2017

Antony D Karelis

2

1 reference

17 November 2017

Denis Prud'homme

3

1 reference

17 November 2017

Vanessa Primeau

4

1 reference

17 November 2017

Martin Brochu

5

1 reference

17 November 2017

22 October 2009

1 reference

17 November 2017

1 reference

17 November 2017

18

1 reference

17 November 2017

5

1 reference

17 November 2017

911-917

1 reference

Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects.

17 November 2017

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.364

Cardiovascular mortality in overweight subjects: the key role of associated risk factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.364

Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.364

Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.364

Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.364

Prevalence of uncomplicated obesity in an Italian obese population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.364

Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.364

All obese individuals are not created equal: insulin resistance is the major determinant of cardiovascular disease in overweight/obese individuals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.364

Metabolically healthy but obese individuals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.364

Metabolic and body composition factors in subgroups of obesity: what do we know?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.364

Are there persons who are obese, but metabolically healthy?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.364

High adiponectin concentrations are associated with the metabolically healthy obese phenotype

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.364

What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.364

The metabolically healthy but obese individual presents a favorable inflammation profile

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.364

Are natural killer cells protecting the metabolically healthy obese patient?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.364

Identification and characterization of metabolically benign obesity in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.364

Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.364

Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.364

The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.364

Metabolically healthy but obese women: effect of an energy-restricted diet

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.364

Inclusion of C-reactive protein in the identification of metabolically healthy but obese (MHO) individuals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.364

The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.364

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.364

Apolipoprotein B: a predictor of inflammatory status in postmenopausal overweight and obese women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.364

Psychosocial correlates of cardiorespiratory fitness and muscle strength in overweight and obese post-menopausal women: a MONET study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.364

Relationship between insulin sensitivity and the triglyceride-HDL-C ratio in overweight and obese postmenopausal women: a MONET study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.364

Association of cardiorespiratory fitness with insulin sensitivity in overweight and obese postmenopausal women: a Montreal Ottawa New Emerging Team study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.364

Do adaptive changes in metabolic rate favor weight regain in weight-reduced individuals? An examination of the set-point theory

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.364

Measurement of energy expenditure in humans by doubly labeled water method

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.364

Metabolic and behavioral characteristics of metabolically obese but normal-weight women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.364

Metabolically Healthy but Obese Women Have an Intermediate Cardiovascular Risk Profile Between Healthy Nonobese Women and Obese Insulin-Resistant Women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.364

Elevated serum ferritin levels predict new-onset type 2 diabetes: results from the EPIC-Norfolk prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.364

The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2009.364

31 March 2020

Identifiers

DOI

10.1038/OBY.2009.364

1 reference

17 November 2017

1 reference